Blockade of adenosine A2B receptors ameliorates murine colitis.
Blockade of adenosine A2B receptors ameliorates murine colitis.
复制标题
腺苷A2B受体的阻断可改善鼠类结肠炎。
DOI:
10.1038/bjp.2008.227
复制
发表时间:
2008-09
影响因子:
7.3
通讯作者:
Sitaraman, S. V.
中科院分区:
文献类型:
--
作者:
Kolachala, V. L.;Ruble, B. K.;Vijay-Kumar, M.;Wang, L.;Mwangi, S.;Figler, H. E.;Figler, R. A.;Srinivasan, S.;Gewirtz, A. T.;Linden, J.;Merlin, D.;Sitaraman, S. V.
The adenosine 2B (A2B) receptor is the predominant adenosine receptor expressed in the colon. Acting through the A2B receptor, adenosine mediates chloride secretion, as well as fibronectin and interleukin (IL)-6 synthesis and secretion in intestinal epithelial cells. A2B receptor mRNA and protein expression are increased during human and murine colitis. However, the effect of the A2B receptor in the activation of the intestinal inflammatory response is not known. In this study, we examined the effect of A2B receptor antagonism on murine colitis. Dextran sodium sulphate (DSS)-treated mice and piroxicam-treated IL-10−/− mice were used as animal models of colitis. The A2B receptor-selective antagonist, ATL-801, was given in the diet. Mice fed ATL-801 along with DSS showed a significantly lower extent and severity of colitis than mice treated with DSS alone, as shown by reduced clinical symptoms, histological scores, IL-6 levels and proliferation indices. The administration of ATL-801 prevented weight loss, suppressed the inflammatory infiltrate into colonic mucosa and decreased epithelial hyperplasia in piroxicam-treated IL-10−/− mice. IL-6 and keratinocyte-derived chemokine (KC) concentrations in the supernatants of colonic organ cultures from colitic mice were significantly reduced by ATL-801 administration. Taken together, these data demonstrate that the intestinal epithelial A2B receptor is an important mediator of pro-inflammatory responses in the intestine and that A2B receptor blockade may be an effective therapeutic strategy to treat inflammatory bowel disease.
登录
查看更多内容
影响因子:
5
作者:
Mabley, J;Soriano, F;Szabó, C
通讯作者:
Szabó, C
影响因子:
3.1
作者:
Vetuschi, A;Latella, G;Gaudio, E
通讯作者:
Gaudio, E
影响因子:
29.4
作者:
Odashima, M;Bamias, G;Cominelli, F
通讯作者:
Cominelli, F
DOI:
10.1084/jem.20050421
发表时间:
2005-10-03
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Li C;Dandridge KS;Di A;Marrs KL;Harris EL;Roy K;Jackson JS;Makarova NV;Fujiwara Y;Farrar PL;Nelson DJ;Tigyi GJ;Naren AP
通讯作者:
Naren AP
影响因子:
29.4
作者:
Castaneda, FE;Walia, B;Sitaraman, SV
通讯作者:
Sitaraman, SV